- Generic name
- Eltrombopag
- Strength
- 50 mg
- Dosage form
- Tablet
- Manufactured by
- Renata PLC.
R-Pag 50 Tablet
About R-Pag 50 Tablet
The tablet R-Pag 50 contains Eltrombopag and is made by Renata PLC. For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.
There are 7 brands of Eltrombopag listed in Bangladesh.
What is R-Pag 50 Tablet?
R-Pag 50 is a tablet from Renata PLC., with the generic name Eltrombopag. Eltrombopag tablets should be used only in patients with chronic hepatitis C whose degree of thrombocytopenia prevents the initiation of interferon-based therapy or limits the ability to maintain interferon-based therapy. For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. Ask your doctor or pharmacist if you are unsure about it.
Uses of R-Pag 50
For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. For the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. Ask your doctor whether it is right for your condition.
How to use R-Pag 50
R-Pag 50 is taken by mouth. Swallow the tablet with water. Complete the course exactly as prescribed. Do not change the dose or stop early without asking your doctor.
Side effects of R-Pag 50
He following clinically significant adverse reactions associated with Eltrombopag are described in other sections. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. Eltrombopag may increase the risk of severe and potentially life-threatening hepatotoxicity. Keep out of reach of children.
Frequently asked questions
Why is R-Pag 50 prescribed?
For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. For the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.
How is R-Pag 50 used?
R-Pag 50 is taken by mouth. Swallow the tablet with water.
Can R-Pag 50 cause side effects?
He following clinically significant adverse reactions associated with Eltrombopag are described in other sections. Tell your doctor if any side effect bothers you or does not go away.
Who should be careful with R-Pag 50?
The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. Eltrombopag may increase the risk of severe and potentially life-threatening hepatotoxicity.
Alternative brands of Eltrombopag
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.